GSK plc announced a 1% year-over-year sales increase to £8 billion in Q2 2025, with Specialty Medicines driving growth. Earnings per share and operating profit also saw significant...
Adidas AG reports a 2.2% increase in Q2 net sales to €5.95 billion, with significant growth in net income and EPS. Despite these gains, US tariffs pose challenges, potentially addi...
Philips reports a 2.8% sales decline to €4.34 billion in Q2 2025, with net income plummeting by 46.9%. The company maintains its sales growth forecast for 2025 and adjusts EBITDA e...
Volkswagen Group's Q2 sales revenue fell by 3% to €80.8 billion, with a notable 36.3% drop in earnings after tax. Despite challenges, the operating margin met expectations, signali...
Johnson & Johnson announced a 5.8% increase in Q2 sales to $23.7 billion, surpassing expectations. With EPS up 18.7% and net earnings reaching $5.5 billion, the company also raised...
Walgreens Boots Alliance Inc. reports a 3.9% sales increase to $38.6 billion in Q2, outperforming expectations with a reduced net loss. CEO Tim Wentworth highlights strategic progr...
Walgreens Boots Alliance Inc. reports a 3.9% sales increase to $38.6 billion in Q2 of fiscal 2025, outperforming estimates. Despite a reduced net loss, challenges remain with weake...
Walgreens Boots Alliance Inc. announced a 3.9% increase in Q2 sales to $38.6 billion, outperforming expectations. Despite a reduced net loss, challenges remain, including legal set...
Walgreens Boots Alliance Inc. reports a 3.9% sales increase to $38.6 billion in Q2 fiscal 2025, surpassing analysts' expectations. The company sees a reduced net loss and improved ...
Walgreens Boots Alliance Inc. reports a 3.9% increase in Q2 sales to $38.6 billion, beating estimates. The company also sees a reduced net loss, signaling positive financial adjust...
Walgreens Boots Alliance Inc. reports a 3.9% increase in Q2 sales to $38.6 billion, beating estimates. The company reduces net loss significantly, with CEO Tim Wentworth highlighti...
